UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future

Toxicology and applied pharmacology, 2016-05, Vol.299, p.70-77

2016

Link zum Volltext

Verfügbarkeit prüfen

Current understanding of interactions between nanoparticles and the immune system

Toxicology and applied pharmacology, 2016-05, Vol.299, p.78-89

2016

Link zum Volltext

Verfügbarkeit prüfen

Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines

Journal of controlled release, 2013-12, Vol.172 (2), p.456-466

2013

Link zum Volltext

Verfügbarkeit prüfen

Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology

ACS nano, 2020-08, Vol.14 (8), p.9221-9227

2020

Link zum Volltext

Verfügbarkeit prüfen

Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory

Frontiers in immunology, 2022-10, Vol.13, p.984252-984252

Dobrovolskaia, Marina A.

2022

Link zum Volltext

Verfügbarkeit prüfen

Roadmap and strategy for overcoming infusion reactions to nanomedicines

Nature nanotechnology, 2018-12, Vol.13 (12), p.1100-1108

2018

Link zum Volltext

Verfügbarkeit prüfen

Minireview: Nanoparticles and the Immune System

Endocrinology (Philadelphia), 2010-02, Vol.151 (2), p.458-465

2010

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions

ACS nano, 2017-01, Vol.11 (1), p.12-18

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification and Avoidance of Potential Artifacts and Misinterpretations in Nanomaterial Ecotoxicity Measurements

Environmental science & technology, 2014-04, Vol.48 (8), p.4226-4246

2014

Link zum Volltext

Verfügbarkeit prüfen

A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity

Biomaterials, 2016-09, Vol.101, p.296-309

2016

Link zum Volltext

Verfügbarkeit prüfen

Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy

Journal of controlled release, 2015-12, Vol.220 (Pt B), p.571-583

Dobrovolskaia, Marina A.

2015

Link zum Volltext

Verfügbarkeit prüfen

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles

Nanomedicine, 2009-06, Vol.5 (2), p.106-117

2009

Link zum Volltext

Verfügbarkeit prüfen

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine

Nature protocols, 2011-12, Vol.6 (12), p.2022-2034

2011

Link zum Volltext

Verfügbarkeit prüfen

Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles

Nanomedicine, 2014-10, Vol.10 (7), p.1453-1463

2014

Link zum Volltext

Verfügbarkeit prüfen

Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics

Expert opinion on drug delivery, 2015-07, Vol.12 (7), p.1163-1175

2015

Link zum Volltext

Verfügbarkeit prüfen

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory

Integrative biology (Cambridge), 2013-01, Vol.5 (1), p.66-73

2013

Link zum Volltext

Verfügbarkeit prüfen

Characterization of nanoparticles for therapeutics

Nanomedicine (London, England), 2007-12, Vol.2 (6), p.789

2007

Link zum Volltext

Verfügbarkeit prüfen

Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations

Nanomedicine, 2018-04, Vol.14 (3), p.977-990

2018

Link zum Volltext

Verfügbarkeit prüfen

Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm

Frontiers in immunology, 2021-04, Vol.12, p.642860-642860

2021

Link zum Volltext

Verfügbarkeit prüfen

Toll receptors, CD14, and macrophage activation and deactivation by LPS

Microbes and infection, 2002-07, Vol.4 (9), p.903-914

2002

Link zum Volltext

Verfügbarkeit prüfen

Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics

Advanced drug delivery reviews, 2019-02, Vol.141, p.3-22

2019

Link zum Volltext

Verfügbarkeit prüfen

To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives

Advanced drug delivery reviews, 2022-01, Vol.180, p.114079, Article 114079

2022

Link zum Volltext

Verfügbarkeit prüfen

Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA

Nanomedicine, 2015-11, Vol.11 (8), p.1925-1938

2015

Link zum Volltext

Verfügbarkeit prüfen

Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro

Nanomedicine (London, England), 2011-09, Vol.6 (7), p.1175

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunological properties of engineered nanomaterials

Nature nanotechnology, 2007-08, Vol.2 (8), p.469-478

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 148

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieMolecules

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(148)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Humans
(80)
Nanoparticles
(76)
Life Sciences & Biomedicine
(73)
Animals
(52)
Pharmacology & Pharmacy
(41)
Science & Technology - Other Topics
(39)
Nanoscience & Nanotechnology
(38)
Nanoparticles - Chemistry
(32)
Nanotechnology
(29)
Materials Science
(27)
Technology
(24)
Biochemistry & Molecular Biology
(23)
Biochemical Research Methods
(21)
Materials Science, Multidisciplinary
(21)
Chemistry
(20)
Immunotoxicity
(20)
Physical Sciences
(20)
Chemistry, Multidisciplinary
(19)
Nanomedicine
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future

Current understanding of interactions between nanoparticles and the immune system

Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines

Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology

Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory

Roadmap and strategy for overcoming infusion reactions to nanomedicines

Minireview: Nanoparticles and the Immune System

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions

Identification and Avoidance of Potential Artifacts and Misinterpretations in Nanomaterial Ecotoxicity Measurements

A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity

Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine

Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles

Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory

Characterization of nanoparticles for therapeutics

Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations

Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm

Toll receptors, CD14, and macrophage activation and deactivation by LPS

Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics

To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives

Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA

Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro

Immunological properties of engineered nanomaterials

Aktive Filter

Suchergebnisse filtern